These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35004697)

  • 1. Comprehensive Analysis Revealed that
    Chen Z; Guo Y; Zhao D; Zou Q; Yu F; Zhang L; Xu L
    Front Cell Dev Biol; 2021; 9():808208. PubMed ID: 35004697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma.
    Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M
    Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.
    Tu Z; Wang X; Cai H; Sheng Y; Wu L; Huang K; Zhu X
    Aging (Albany NY); 2023 Mar; 15(6):2136-2157. PubMed ID: 36961395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
    Hu X; Zhu H; Zhang X; He X; Xu X
    Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
    Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome.
    Soltan MA; Alhanshani AA; Shati AA; Alqahtani YA; Alshaya DS; Alharthi J; Altalhi SA; Fayad E; Zaki MSA; Eid RA
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
    Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
    Front Genet; 2021; 12():687778. PubMed ID: 34594356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serpin Family A Member 1 Is Prognostic and Involved in Immunological Regulation in Human Cancers.
    Kuai X; Lv J; Zhang J; Xu M; Ji J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer.
    Qiu MJ; Wang QS; Li QT; Zhu LS; Li YN; Yang SL; Xiong ZF
    Front Mol Biosci; 2021; 8():559800. PubMed ID: 34109209
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
    Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y
    Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525
    [No Abstract]   [Full Text] [Related]  

  • 12. Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.
    Zhou B; Gao S
    Front Mol Biosci; 2021; 8():648402. PubMed ID: 33968987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor suppressor gene cyclin-dependent kinase inhibitor 2A wild-type and A148T mutant on the cell cycle of human ovarian cancer cells.
    Bian Z; Yu Y; Yang T; Quan C; Sun W; Fu S
    Oncol Lett; 2014 Apr; 7(4):1229-1232. PubMed ID: 24944698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Pan-Cancer Analysis Confirmed That ATG5 Promoted the Maintenance of Tumor Metabolism and the Occurrence of Tumor Immune Escape.
    Xu C; Zang Y; Zhao Y; Cui W; Zhang H; Zhu Y; Xu M
    Front Oncol; 2021; 11():652211. PubMed ID: 33842365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
    Breyer J; Wirtz RM; Erben P; Worst TS; Stoehr R; Eckstein M; Bertz S; Sikic D; Denzinger S; Burger M; Hartmann A; Otto W;
    Clin Genitourin Cancer; 2018 Aug; 16(4):248-256.e2. PubMed ID: 29525349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer.
    Nie K; Li J; Peng L; Zhang M; Huang W
    Front Mol Biosci; 2022; 9():837393. PubMed ID: 35647025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BOP1 Used as a Novel Prognostic Marker and Correlated with Tumor Microenvironment in Pan-Cancer.
    Li W; Song P; Zhao M; Gao L; Xie J; You C
    J Oncol; 2021; 2021():3603030. PubMed ID: 34603446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.